Qiagen Acquires Chinese Firm

Expanding its position in China, Qiagen N.V. (Venlo, The Netherlands) has acquired Tianwei Times (Beijing, China) for about U.S.$2 million in cash plus potential earn-outs over two years estimated at another $2 million.

Tianwei is a leading developer, manufacturer, and supplier of nucleic acid sample preparation consumables in China. The acquisition expands Qiagen's position as the leading supplier of products and technologies for preanalytical sample preparation in the rapidly growing Chinese market. Qiagen expects this transaction to contribute about $1.5-2.0 million in sales of preanalytical and related products in 2006.

"Over the course of 2004, Qiagen significantly expanded its position in China,” explained Peer M. Schatz, CEO of Qiagen. "We established a focused, local marketing presence, including an office in Shanghai, and strengthened our distribution channels with Gene Company as the major distributor. Tianwei will complement these activities with its research, manufacturing, and marketing organization and will allow us to tailor preanalytical solutions for nucleic acids and proteins to meet the specific needs of the local scientific community.”

"Qiagen's global presence, its recognized excellence, and its operational strength make Qiagen a perfect partner to serve the expanding Chinese research markets,” observed Chunxiang Wang, founder of Tianwei.




Related Links:
Qiagen